Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies

Tenn Med. 1997 May;90(5):189-92.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol, LDL / blood
  • Coronary Disease / epidemiology
  • Coronary Disease / prevention & control*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Finland / epidemiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Hypercholesterolemia / drug therapy*
  • Lovastatin / analogs & derivatives*
  • Lovastatin / therapeutic use
  • Male
  • Middle Aged
  • Morbidity
  • Pravastatin / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Scotland / epidemiology
  • Simvastatin

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lovastatin
  • Simvastatin
  • Pravastatin